These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27037013)

  • 41. Heritable CRISPR/Cas9-mediated genome editing in the yellow fever mosquito, Aedes aegypti.
    Dong S; Lin J; Held NL; Clem RJ; Passarelli AL; Franz AW
    PLoS One; 2015; 10(3):e0122353. PubMed ID: 25815482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome Editing in Mice.
    Hansen LA; Füchtbauer EM
    Methods Mol Biol; 2019; 1961():249-254. PubMed ID: 30912050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid and efficient analysis of gene function using CRISPR-Cas9 in Xenopus tropicalis founders.
    Shigeta M; Sakane Y; Iida M; Suzuki M; Kashiwagi K; Kashiwagi A; Fujii S; Yamamoto T; Suzuki KT
    Genes Cells; 2016 Jul; 21(7):755-71. PubMed ID: 27219625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diversity of CRISPR-Cas immune systems and molecular machines.
    Barrangou R
    Genome Biol; 2015 Nov; 16():247. PubMed ID: 26549499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Cpf1 CRISPR-Cas protein expands genome-editing tools.
    Fagerlund RD; Staals RH; Fineran PC
    Genome Biol; 2015 Nov; 16():251. PubMed ID: 26578176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9.
    LaFountaine JS; Fathe K; Smyth HD
    Int J Pharm; 2015 Oct; 494(1):180-94. PubMed ID: 26278489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
    Qiu M; Glass Z; Xu Q
    Biomacromolecules; 2019 Sep; 20(9):3333-3339. PubMed ID: 31342740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
    Xu S
    J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
    Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
    Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A possible aid in targeted insertion of large DNA elements by CRISPR/Cas in mouse zygotes.
    Nakao H; Harada T; Nakao K; Kiyonari H; Inoue K; Furuta Y; Aiba A
    Genesis; 2016 Feb; 54(2):65-77. PubMed ID: 26713866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Harnessing Type I and Type III CRISPR-Cas systems for genome editing.
    Li Y; Pan S; Zhang Y; Ren M; Feng M; Peng N; Chen L; Liang YX; She Q
    Nucleic Acids Res; 2016 Feb; 44(4):e34. PubMed ID: 26467477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pervasive Genotypic Mosaicism in Founder Mice Derived from Genome Editing through Pronuclear Injection.
    Oliver D; Yuan S; McSwiggin H; Yan W
    PLoS One; 2015; 10(6):e0129457. PubMed ID: 26053263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient Virus-Mediated Genome Editing in Plants Using the CRISPR/Cas9 System.
    Ali Z; Abul-faraj A; Li L; Ghosh N; Piatek M; Mahjoub A; Aouida M; Piatek A; Baltes NJ; Voytas DF; Dinesh-Kumar S; Mahfouz MM
    Mol Plant; 2015 Aug; 8(8):1288-91. PubMed ID: 25749112
    [No Abstract]   [Full Text] [Related]  

  • 57. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Next Generation Transgenic Rat Model Production.
    Filipiak WE; Hughes ED; Gavrilina GB; LaForest AK; Saunders TL
    Methods Mol Biol; 2019; 2018():97-114. PubMed ID: 31228153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Precise Genome Editing of Drosophila with CRISPR RNA-Guided Cas9.
    Gratz SJ; Harrison MM; Wildonger J; O'Connor-Giles KM
    Methods Mol Biol; 2015; 1311():335-48. PubMed ID: 25981484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.